Abbott launches next-generation embolic protection system in Europe

By Lisa Kerner

Charlotte, N.C., Sept. 13 - Abbott Laboratories announced the CE Mark approval and European launch of its Emboshield PRO Embolic Protection System. The system captures and removes particles of atherosclerotic plaque dislodged during carotid artery stenting procedures that can cause stroke and other complications.

Because it is more radiopaque, the Emboshield PRO provides improved visibility during X-ray than the previous-generation Emboshield Embolic Protection System, according to a company news release.

In addition, the new device's shorter length allows it to cross tighter blockages and makes it easier to use in patients with challenging carotid anatomies. Proprietary barewire technology provides filter stability.

Abbott is a broad-based health care company based in Abbott Park, Ill.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.